Dr Peter Smith, CEO,
Alchemia


Charles Grant, Chairman,
American Australian Association


Bruce L. Rogers, Ph.D.
Biorelationships Conference Chairman
American Australian Association of New England

Dr.Igor Gonda, Ph.D.
President and Chief Executive Officer
Aradigm

Dr. Anna Lavelle, Chief Executive Officer
AusBiotech

Dr Susan Pond AM MD DSc FRACP FTSE
Chairman, AusBiotech Limited
AusBiotech

Professor Stephen Livesey, CEO
The Australian Stem Cell Centre

Sue MacLeman, Chief Executive Officer
Benitec Ltd

Dr. Alex Szabo, VP Business Development
Bionomics

Michael Levy, Vice President,
Alliance Management
Bristol-Myers Squibb

Dr. Greg Collier, CEO
ChemGenex Pharmaceuticals

Dr. Mikael Hirsch
CSIRO

Dr. Ian Frazer
Diamantina Institute

Dr. Magovcevic-Liebisch, General Counsel and EVP,
Corporate Communications,
Dyax

Albert Sokol, Partner,
Edwards Angell Palmer & Dodge LLP

Andrew Baker,
GBS Venture Partners

Alison Coutts, Executive Director
eG Capital

Bruce Pratt, VP of Science Development,
Genzyme Corporation

Garry Redlich, Founding CEO and Managing Director
Implicit Bioscience Pty Ltd

Barbara Yanni, Vice President and
Chief Licensing Officer
Merck & Co., Inc

Dr. John W. Holaday
Montgomery Pacific Group

Dr. Ed Mascioli, M.D.
MPM Capital

Dr. Campbell Murray, Managing Director,
Novartis Venture Fund

Michael Aldridge, CEO,
Peplin Limited

Mel Bridges, Chairman
Peptech Limited

Katerina Karanikolopoulos, Vice-President
Business Development
Phosphagenics

Justus Homberg, CEO
Progen

Bill Griffith, Global Life Sciences Industry Director
Reed Smith

Jim Sherblom - Managing General Partner
Seaflower

Gangfeng Xu, Sr. Director, Head of Licensing and Business,
Wyeth

Home | Agenda | Venue | Sponsors | Companies | Speakers | Conference 2006